Curis
CRIS • NASDAQ
Curis is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James E. Dentzer, with a market cap of $11.8M.
CEOJames E. Dentzer
Next Earnings
Upcoming earnings announcement for Curis
Date
Tuesday, May 5, 2026 (in 3 months)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.43
Revenue Estimate
$3.0M
Earnings History
Past 11 earnings reports for Curis
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 6, 2025 | Q3 2025 | -$0.49Est: -$0.61 | +19.7% | $3.2MEst: $2.9M | +10.0% |  10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.68Est: -$1.71 | +60.2% | $2.7MEst: $2.5M | +8.1% | 10-Q |
| May 6, 2025 | Q1 2025 | -$1.25Est: -$1.26 | +0.8% | $2.4MEst: $2.6M | -8.5% | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$1.25Est: -$1.36 | +8.1% | $3.3MEst: $2.7M | +24.3% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$1.70Est: -$1.91 | +11.0% | $2.9MEst: $2.4M | +23.7% | 10-Q |
| Aug 1, 2024 | Q2 2024 | -$2.03Est: -$1.67 | -21.6% | $2.5MEst: $2.1M | +23.6% | 10-Q |
| May 7, 2024 | Q1 2024 | -$2.05Est: -$2.12 | +3.3% | $2.1MEst: $2.4M | -13.1% | 10-Q |
| Feb 8, 2024 | Q4 2023 | -$2.03Est: -$2.11 | +3.8% | $2.7MEst: $3.0M | -10.7% | 10-K |
| Nov 2, 2023 | Q3 2023 | -$2.13Est: -$2.33 | +8.6% | $2.8MEst: $2.5M | +11.5% | — |
| Aug 3, 2023 | Q2 2023 | -$2.40Est: -$2.40 | 0.0% | $2.2MEst: $2.6M | -14.5% | 10-Q |
| May 4, 2023 | Q1 2023 | -$2.40Est: -$2.00 | -20.0% | $2.3MEst: $2.5M | -7.4% | 10-Q |